drugset / Trial / NCT05191290

Comparison of Biocompatibility of Plasmapheresis Procedures With Citrate and Heparin Anticoagulation

NCT05191290

Phase 4 Completed 15 enrolled University Medical Centre Ljubljana
RandomizedCrossoverOpen-labelTreatment

Summary

Membrane plasmapheresis is one of the methods for treating immune diseases. Plasmapheresis removes autoantibodies and immune complexes, paraproteins, lipoproteins and reduces the concentration of cytokines. In membrane plasmapheresis, plasma is separated from blood cells by a highly permeable membrane. The filtered plasma is then discarded and replaced with replacement fluid. During the procedure, there is an activation of the coagulation system, because of the extracorporeal blood circulation. The anticoagulation during the procedure is therefore necessary.

Timeline

Start
2022-01-21
Primary completion
2022-12-30
Completion
2022-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 2000 iu Intravenous
Subject sodium citrate Unknown 27 mmol Intravenous

Indications

No indication recorded.